Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03037749 · ClinicalTrials.gov registry record · Early Phase 1
Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence
A Early Phase 1 study of Alcohol Consumption and Domestic Violence, sponsored by University of New Mexi.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT03037749: Completed Early Phase 1 study of Alcohol Consumption and Domestic Violence, sponsored by University of New Mexi.
NCT03037749 is a Early Phase 1 study of Alcohol Consumption and Domestic Violence that has completed, run by University of New Mexi. The registered enrollment target is 42 participants, below the 373-participant average among 18 other Alcohol Consumption trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03037749, a Early Phase 1 study of Alcohol Consumption and Domestic Violence, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Intimate partner violence (IPV) is a serious public health problem costing $8.3 billion per year with over $6 billion in direct medical and mental health costs alone. Alcohol is present in most incidents of IPV, and contributes to more frequent and severe IPV incidents. These facts, coupled with the fact that there are no effective interventions for IPV, make understanding mechanisms through which alcohol is associated with IPV critical.
Primary Outcome
electroencephalography. Each participant's individual neurophysiological responses will be collected and then aggregated at the conclusion of the study for between-group analyses. Greater alpha and beta frequencies relative to reduced to theta and delta frequencies indicate greater cortical arousal. The experimental conditions of this study will allow us to determine if distressed violent partners experience greater cortical arousal in certain conditions.
Conditions Studied
Interventions
- DRUG Alcohol beverage
- DRUG Placebo beverage
Study Locations (1)
New Mexico
- University of New Mexico - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2015-09-27 |
| Est. Completion | 2018-08-31 |
| Phase | Early Phase 1 |
What the finished NCT03037749 record still lists
NCT03037749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 373-participant average among 18 other Alcohol Consumption trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Alcohol Consumption appearing as the primary indexed condition, and to 2 interventions - of which Alcohol beverage is the first listed.
NCT03037749 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT03037749 about?
NCT03037749 is a clinical study titled "Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence". Intimate partner violence (IPV) is a serious public health problem costing $8.3 billion per year with over $6 billion in direct medical and mental health costs alone. Alcohol is present in most incidents of IPV, and contributes to more frequent and severe IPV incidents. These facts, coupled with the...
What is the current status of trial NCT03037749?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 42 participants. The study started on 2015-09-27. Estimated completion is 2018-08-31.
What conditions does trial NCT03037749 study?
This clinical trial studies the following conditions: Alcohol Consumption, Domestic Violence.
What interventions are being tested in trial NCT03037749?
The interventions under investigation include: Alcohol beverage (DRUG), Placebo beverage (DRUG).
Who is sponsoring clinical trial NCT03037749?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03037749 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Consumption
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03037749's enrollment target sits among peer trials
42 15th of 18 higher than 4 of 18 other Alcohol Consumption trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Consumption trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phosphatidylethanol and Other Ethanol Consumption Markers
RECRUITING · NA
-
Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial
RECRUITING · NA
-
Social Facilitation of Alcohol Effects and Alcohol Misuse in Young Adults
RECRUITING · NA
-
Probenecid Administration for Alcohol Craving and Consumption
RECRUITING · Phase 2
-
Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study
RECRUITING · NA
-
Drinking in Young Adult Duos (DYAD) Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI